Table 4. Antimicrobial susceptibility testing for Klebsiella pneumoniae.
| Antibiotics | Resistant | Intermediate | Sensitive |
|---|---|---|---|
| AMP | 54(100%) | 00(0%) | 00(0%) |
| AMC | 54(100%) | 00(0%) | 00(0%) |
| PTZ | 35(64.8%) | 3(5.55%) | 16(29.6%) |
| FOX | 26(48.1%) | 1(1.85%) | 27(50%) |
| CAZ | 45(83.33%) | 00(0%) | 9(16.66%) |
| CTX | 41(75.9%) | 00(0%) | 13(24.1%) |
| CPM | 40(70.4%) | 00(0%) | 14(25.9%) |
| ATM | 38(70.37%) | 00(0%) | 16(29.63%) |
| IMP | 20(37.0%) | 00(0%) | 34(62.96%) |
| MEM | 20(37.0%) | 00(0%) | 34(62.96%) |
| AN | 26(48.1%) | 00(0%) | 28(51.9%) |
| CM | 30(55.5%) | 11(1.85%) | 23(42.6%) |
| CIP | 34(62.96%) | 2(3.7%) | 18(33.33%) |
| TEM | 30(55.5%) | 0(0%) | 24(44.44%) |
Ampicillin (AMP), Amoxicillin-Clavulanic Acid (AMC), Piperacillin-tazobactam (PTZ), Cefoxitin (FOX), Ceftazidime (CAZ), Ceftriaxone (CRO), Cefotaxime (CTX), Cefepime (CFM), Aztronam (ATM), Imipenem (IPM), Meropenem (MEM), Amikacin (AN), Gentamicin (CN), Ciprofloxacin (CIP), Trimethoprim- Sulphomethoxazole (TMP).